Research & Innovation
-
Swedish is home to some of the country's most advanced surgical techniques
Surgical experts at Swedish are saving lives with procedures and technology that not too long ago would have been considered impossible. Learn more.
-
New training simulator supports ECMO excellence at Swedish
A Swedish Foundation-funded device offers realistic patient scenarios for advanced cardiac care team training.
-
Swedish is the first Washington State hospital to offer groundbreaking ALS treatment
Tofersen, a new drug, is the first gene therapy for a familial form of amyotrophic lateral sclerosis.
-
Clinical research expands treatment for heart valve disease
An expert at Swedish explains how recently released results from three clinical studies are bringing new hope to people with heart valve disease.
-
Providence Swedish experts in the media
Your one-stop shop for some of the latest health news featuring Swedish experts.
-
Upcoming studies give hope to people with lupus and MS
Groundbreaking research designed to assess the effectiveness of CAR-T cell therapy on lupus and multiple sclerosis is in the early stages at Swedish.
-
Newly approved drug is a major advancement for patients with ulcerative colitis
Michael Chiorean, M.D., co-director of the IBD Center at Swedish, was an investigator in the study that helped win approval for the new medication.
-
Wish you could get rid of your COVID-19 symptoms sooner? Be part of a new study.
The OakTree study is looking at a new COVID-19 drug to see if it can shorten the time you have symptoms. Learn more about participating.
-
TeamBirth maternity program launches at Providence Swedish
The initiative, a joint venture with the Washington State Hospital Association and others, seeks to ensure shared decision-making processes between birthing parents and clinicians.
-
Swedish implements use of device that more quickly stops postpartum hemorrhage
The Jada System provides immediate intervention for the dangerous condition, allowing more bonding time for birthing parent and baby.
-
Swedish is a destination for innovative, world-class care
Seattle’s KING 5 TV hosted a panel of sought-after Swedish specialists for a conversation about advanced treatments at Swedish and why patients from around the world choose us for their care.
-
Providence Swedish extracorporeal life support program receives award for excellence
The gold award from the Extracorporeal Life Support Association is among the international organization’s highest honors.
-
New residency program addresses OB/GYN shortage
With a groundbreaking program at Swedish, first-year residents are leading change in their field.
-
Revolutionary care for heart valve patients
Swedish offers revolutionary heart care for tricuspid regurgitation. Our experts share treatment options and explain why the new procedure offers new hope.
-
MS treatment at Swedish: visionary research and world-class care
Swedish’s MS Center is the most comprehensive and among the largest in the United States.
-
AACR Project GENIE: Making a worldwide impact in cancer research and precision medicine
As part of an international data-sharing consortium of leading cancer centers, Swedish Cancer Institute and Providence Cancer Institute work together to provide genomic data to Project GENIE.
-
Milestone in procedure to fix leaky hearts
Heart specialists at Swedish recently completed their 500th MitraClip™ procedure for patients with leaky hearts. Learn more about what that means for heart care.
-
Swedish's James Porter, M.D., recognized for achievements in robotic surgery
Swedish First Hill medical director for robotic surgery received this year's Menon Award at the North American Robotic Urology Symposium.
-
Cancer Prevention Resource Roundup
Review information about cancer prevention shared by experts at the Swedish Cancer Institute in this collection of past blog posts.
-
Swedish cancer specialists achieve cellular therapy milestone
Swedish recently hit the 100-patient milestone for Cellular therapy. Learn what the accomplishment means for cancer patients in the region.
- Loading More...